Literature DB >> 26704027

Liver Disease in Patients After the Fontan Operation.

Krishna Pundi1, Kavitha N Pundi2, Patrick S Kamath3, Frank Cetta4, Zhuo Li5, Joseph T Poterucha2, David J Driscoll2, Jonathan N Johnson6.   

Abstract

We reviewed records of all patients with an initial Fontan operation or revision from 1973 to 2012 at our institution (n = 1,138); 195 patients had postoperative liver data available. Cirrhosis was identified by histopathology or characteristic findings on imaging with an associated diagnosis of cirrhosis by a hepatologist. Of 195 patients with biopsy or imaging, 10-, 20-, and 30-year freedom from cirrhosis was 99%, 94%, and 57%, respectively. There were 40 of 195 patients (21%) diagnosed with cirrhosis (mean age at Fontan 10.7 ± 8 years). On multivariate analysis, hypoplastic left heart syndrome was associated with increased risk of cirrhosis (n = 2 of 16, p = 0.0133), whereas preoperative sinus rhythm was protective (p = 0.009). Survival after diagnosis of cirrhosis was 57% and 35%, at 1, and 5 years, respectively. The cause of death was known for 9 patients (5 multiorgan failure, 2 liver failure, and 2 heart failure). In conclusion, there is an incremental occurrence of cirrhosis after the Fontan, which should be considered when designing follow-up protocols for patients after Fontan operation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26704027     DOI: 10.1016/j.amjcard.2015.11.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

1.  Routine Surveillance Catheterization is Useful in Guiding Management of Stable Fontan Patients.

Authors:  Neil D Patel; Patrick M Sullivan; Arash Sabati; Allison Hill; Chelsea Maedler-Kron; Shengmei Zhou; Nick Shillingford; Roberta Williams; Cheryl Takao; Sarah Badran
Journal:  Pediatr Cardiol       Date:  2020-01-24       Impact factor: 1.655

2.  The Fontan extracardiac conduit: one size does not fit all.

Authors:  Frank Cetta; Harold M Burkhart
Journal:  Transl Pediatr       Date:  2018-07

Review 3.  Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.

Authors:  Anastacia M Garcia; Jonathan-Thomas Beatty; Stephanie J Nakano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-28       Impact factor: 4.733

Review 4.  Screening modalities for the diagnosis of Fontan-associated liver disease: evidence from the past for future development.

Authors:  Saviga Sethasathien; Krit Leemasawat; Suchaya Silvilairat; Rekwan Sittiwangkul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

5.  Liver function monitoring in Fontan-procedure patients: audit of current practice across South Wales.

Authors:  Elliott J Carande; Gergely Szantho
Journal:  Br J Cardiol       Date:  2021-06-02

6.  Risk factors for Fontan-associated hepatocellular carcinoma.

Authors:  Tomomi Kogiso; Takaomi Sagawa; Makiko Taniai; Eriko Shimada; Kei Inai; Tokuko Shinohara; Katsutoshi Tokushige
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

Review 7.  Heart transplantation for adults with congenital heart disease: current status and future prospects.

Authors:  Hikaru Matsuda; Hajime Ichikawa; Takayoshi Ueno; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-04-24

Review 8.  Imaging of Fontan-associated liver disease.

Authors:  Jonathan R Dillman; Andrew T Trout; Tarek Alsaied; Anita Gupta; Adam M Lubert
Journal:  Pediatr Radiol       Date:  2020-08-18

9.  Non-invasive assessment of liver alterations in Senning and Mustard patients.

Authors:  Nicole Nagdyman; Siegrun Mebus; Johanna Kügel; Reinhart Zachoval; Dirk-André Clevert; Siegmund Lorenz Braun; Guido Haverkämper; Bernd Opgen-Rhein; Felix Berger; Sophia Horster; Jörg Schoetzau; Claudia Pujol Salvador; Ulrike Bauer; John Hess; Peter Ewert; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

10.  Commentary: Hepatocellular carcinoma: A threat for patients with Fontan circulation.

Authors:  Juan Contreras; David Faraoni
Journal:  JTCVS Tech       Date:  2020-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.